Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03190278Phase 1Active Not Recruiting
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia
PrincipalinvestigatorStart date: 2017-06-19

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Weill Medical College of Cornell University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Heng Mei, Doctor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

He Huang, doctor

Zhejiang University

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Jorge E Cortes, MD

Augusta University

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Peihua Lu, MD/PHD

HeiBei YanDa Ludaopei hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

wenting Hu

Shanghai children's medical center

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Olu Lawson

SystImmune Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Daniel Pollyea, MD

University of Colorado, Denver

Moderately Similar
5 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Liping Dou, Dr.

Chinese PLA General Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Daihong Liu, doctor

Chinese PLA General Hospital

Moderately Similar
8 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

zhiguo Long

Shanghai Pudong Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03190278Phase 1PrincipalInvestigator

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia
Active Not Recruiting

All 1 trials loaded